-
Beilu Pharmaceutical Gadopentetate Meglumine Injection Passed the Consistency Evaluation of Generic Drugs
Time of Update: 2021-07-31
According to relevant national policies, appropriate support will be given to medical insurance payment for drug varieties that have passed the consistency evaluation, and medical institutions will give priority to purchase and use in clinical practice .
-
Mid-term transcripts of 126 pharmaceutical companies!
Time of Update: 2021-07-31
Looking at the list of TOP10 net profit growth forecasts for the Chinese medicine sector's interim results, the first thing that comes into view is Tai'antang, which has a net profit of more than 500 million yuan and a year-on-year increase of nearly 20 times .
-
The State Food and Drug Administration held a key laboratory work exchange and promotion meeting
Time of Update: 2021-07-31
On March 5, the State Food and Drug Administration held a key laboratory work exchange and promotion meeting to analyze the situation, exchange experience, clarify tasks, and promote the work of key laboratories to a new level .
-
The State Food and Drug Administration released the catalog of generic drug reference preparations (43rd batch)
Time of Update: 2021-07-31
6mg/5ml Avion Pharmaceuticals LLC No imported original research drugs American Orange Book Sildenafil Citrate Dry Suspension Sildenafil Sitrate For Oral Suspension 10mg/mL Upjohn EESV No imported original research drugs EU listing Methotrexate Disodium Solution For Injection In Pre-Filled Syringe/Metoject、Metex 50mg/ml medac Gesellschaft für klinische Spezialpräparate mbH Enzalutamide Tablets 80mg アステラス Ketoprofen Cataplasms 30mg,10cm×14cm Tizanidine Hydrochloride Granules / Ternelin 0.
-
The State Drug Administration issued a notice on the issuance of the "Administrative Measures for Drug Inspection (Trial)"
Time of Update: 2021-07-31
On May 28, in order to implement the "Drug Administration Law" and the "Vaccine Administration Law", further standardize drug inspection behavior, and promote drug supervision work to adapt to the n
-
The integration of processing of Chinese medicinal materials and production of decoction pieces has advantages
Time of Update: 2021-07-31
Regarding the integration of origin processing and decoction pieces production, the author proposes to build a batch of single-variety decoction pieces factories and regional decoction pieces factories in the main producing areas of authentic medicinal materials, and concentrate and divert flows through the storage and logistics base of Chinese medicinal materials to achieve "Internet +" unified national distribution Directly with one station .
-
Symposium on Innovation and Development of Medical Devices Held in Beijing
Time of Update: 2021-07-31
Medicines Medicines Medicines Medical Devices Medical Devices Medical Devices Xu Jinghe emphasized that the joint efforts of the industry and the regulatory authorities are needed to realize the transformation of China from a big country in the manufacture of machinery to a strong country in the manufacture of machinery and to better protect the public's demand for machinery .
-
emegency notice!
Time of Update: 2021-07-31
The provincial procurement platform requires pharmaceutical companies to upload the "Credit Commitment" in a timely manner, which is the follow-up designated action of the implementation plan of the "National Medical Security Administration's Guiding Opinions on Establishing a Pharmaceutical Price and Recruitment Credit Evaluation System" (hereinafter referred to as the "Guiding Opinions") .
-
From Fang Niu Baby to Harvard Ph.D. Returned Scholars Talking About Tibetan Medicine Going Global
Time of Update: 2021-07-31
: Tibetan returned scholars talk about how Tibetan medicine can go to the world China News Agency reporter Ran Wenjuan Nineteen years ago, Yangga became one of the first batch of postgraduates in Tibetan medicine since the establishment of the Tibet Autonomous Region .
-
The State Food and Drug Administration issued the "Announcement on the Registration Items of the Master File of Medical Devices" on the 12th
Time of Update: 2021-07-31
After the materials are successfully submitted, the Approval Center will send the medical device master file registration receipt (Annex 3) to the owner of the master file or its agency .
-
Research shows that the new crown antibody can be retained for at least 9 months
Time of Update: 2021-07-31
In February and March 2020, 85% of the 3000 residents of the village of Vau in northern Italy were tested for the new crown virus .
8% of people infected with the new coronavirus in February and March were still able to detect antibodies by November .
-
The State Food and Drug Administration requests revision of propranolol tablet instructions
Time of Update: 2021-07-31
" For propranolol tablets that have not passed the consistency evaluation, the following content should be added in the item of "Precautions": "Children should use this product with caution, and there are the following tips on children's medication in similar foreign drug inserts" .
-
Researchers reveal the relationship between inflammation and tumor occurrence, development and treatment
Time of Update: 2021-07-31
In acute inflammation, most inflammatory cells can kill pathogens, promote tissue repair, prevent tumor growth, and then play a role in suppressing cancer; once the inflammation does not subside in time, it will turn into chronic inflammation, which may induce a number of malignant tumors.
-
Defeat drug resistance and eradicate cancer cells!
Time of Update: 2021-07-31
Subsequently, the researchers conducted in vivo experiments on ErSO in several preclinical orthotopic and metastatic mouse models that carry xenografts of different human breast cancer cell lines or patient-derived breast tumors .
-
Children with diabetes usher in the first weekly GLP-1 receptor agonist therapy
Time of Update: 2021-07-31
Reference materials:[1] BYDUREON BCise (exenatide extended-release) Approved in the US for the Treatment of Type 2 Diabetes in Pediatric Patients Ages 10 Years and Older.
Retrieved July 23, 2021, from https:// home/20210723005083/en/BYDUREON-BCise-exenatide-extended-release-Approved-in-the-US-for-the-Treatment-of-Type-2-Diabetes-in-Pediatric-Patients-Ages-10-Years- and-Older
-
China Food and Drug Administration: Soliciting opinions on medical device registration self-inspection work regulations
Time of Update: 2021-07-31
Medical Network, July 26, July 23, in order to do a good job in the preparation and revision of the supporting documents of the Regulations on the Supervision and Administration of Medical Devices, t
-
The fifth batch of national procurement started! The injection purchase cycle is extended! (With purchase catalog)
Time of Update: 2021-07-31
This centralized procurement involves 58 varieties and a total of 137 specifications, including oral regular-release dosage forms, sustained-release and controlled-release dosage forms, eye drops, injections, inhalants and other dosage forms (see attached table) .
-
The first class 1 new drug!
Time of Update: 2021-07-31
Text | plus oneOn July 24, the CDE official website showed that Qilu Pharmaceutical submitted and accepted a listing application for a new class 1 drug "Yiluok Tablets" .
-
Antidepressant "Futhioxetine" Chia Tai Tianqing receives first copy approval
Time of Update: 2021-07-31
At present, the product has been marketed in more than 70 countries and regions around the world, including the United States and the European Union, and was officially approved by the State Food and Drug Administration on November 21, 2017 .
Based on the huge patient demand, the market size of antidepressants in China has reached 6.
-
Baiyunshan Pharmaceutical Amlodipine Besylate Tablets have passed the quality and efficacy consistency evaluation of generic drugs
Time of Update: 2021-07-31
As of the announcement date, Baiyunshan Pharmaceutical General Factory has invested approximately RMB 4,378,800 in research and development expenses (unaudited) for the consistency evaluation of the drug .
